A prospective cohort study involving 3,875 CKD participants (2–4 stage) investigated the associations between the baseline plasma IL-6, CRP, fibroblast growth factor 23 (FGF23), and the all-cause mortality. This evidence concerns the gene IL6 and chronic kidney disease.